Latest news
Five things you need to know about using CRISPR/Cas9 commercially
Here are the 5 key facts you need to know, so you can secure the licenses that will protect your product and your company.
21 February 2023
News
Top news
15 February 2023
Welcome to the CRISPR Powerhouse - the power & flexibility of CRISPR/Cas9 for the antibody manufacturing pipeline.
Read more 8 December 2022
Crown Bioscience & ERS Genomics Announce Global CRISPR/Cas9 Licensing Agreement for Genome Editing Patents
Read more 17 November 2022
Gene editing Webinar: Navigating IP, deal-making and regulatory challenges
Read more 26 July 2022
ERS Genomics and Lepton Pharmaceuticals LTD Enter CRISPR/Cas9 License Agreement
Read more